Skin equivalent graft genetically corrected with a COL7A1-encoding SIN retroviral vector
C12-48
Phase 2 small_molecule active
Quick answer
Skin equivalent graft genetically corrected with a COL7A1-encoding SIN retroviral vector for Recessive dystrophic epidermolysis bullosa (RDEB) is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Recessive dystrophic epidermolysis bullosa (RDEB)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active